Background: Cervical cancer has been ranked among the leading causes of deaths among women in Africa. Despite this, priority setting mechanisms used in planning for programmes and interventions that respond to sexual and reproductive health and rights services particularly in cervical cancer prevalence, prevention and treatment have not adequately taken into account research based evidence to respond appropriately. Methods: We adapted the Child Health and Nutrition Research Initiative method. A wide range of stakeholders identified potential research areas in an online survey. A technical working group comprising of 67 participants reviewed the questions for modification and removal of out scope questions. Finally, scoring and ranking was done to provide the top ten priorities questions. Results: “Cost-benefit analysis of systematic human papillomavirus vaccination compared to the current cost of cervical cancer in public health care systems” scored 27. This was followed by two research questions ranked at 24 points: “assessment of women’s and girls’ knowledge on the importance of early cervical cancer screening,” and “human papilloma virus vaccination and contributions of new technologies to the supply and storage of vaccines, including human papillomavirus vaccine”. Conclusion: The study identified 10 priority research questions that can guide the agenda for cervical cancer prevalence, prevention and treatment in the WHO Africa region. The identified priorities will be of use to policy makers, researchers and programmers and other stakeholders who can invest in areas that greatly affect cervical cancer prevalence, prevention and treatment.
References
[1]
Arbyn, M., et al. (2019) Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30482-6/fulltext
[2]
Chalmers, T., Bracken, M.B., Djulbegovic, B., et al. (2014) How to Increase Value and Reduce When Research Priorities Are Set. The Lancet, 383, 156-165. https://doi.org/10.1016/S0140-6736(13)62229-1
[3]
Cooksey, D. (2006) A Review of UK Health Research Funding. http://www.hmtreasury.gov.uk/d/pbr06_cooksey_final_report_636.pdf
[4]
Chalmers, I. and Glasziou, P. (2009) Avoidable Waste in the Production and Reporting of Research Evidence. The Lancet, 374, 86-89. https://doi.org/10.1016/S0140-6736(09)60329-9
[5]
Glasziou, P., Altman, D.G., Bossuyt, P., et al. (2014) Reducing Waste from Incomplete or Unusable Reports of Biomedical Research. The Lancet, 383, 267-276. https://doi.org/10.1016/S0140-6736(13)62228-X
[6]
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R.M., Barregard, L., Bhutta, Z.A., et al. (2017) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, 3, 524-548. http://www.ncbi.nlm.nih.gov/pubmed/27918777 .
[7]
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386 http://www.ncbi.nlm.nih.gov/pubmed/25220842. https://doi.org/10.1002/ijc.29210
[8]
Regional Committee for Africa (2011) Cancer of the Cervix in the African Region: Current Situation and Way Forward. https://apps.who.int/iris/handle/10665/1684
[9]
Coleman, M.P. (2014) Cancer Survival: Global Surveillance Will Stimulate Health Policy and Improve Equity. The Lancet, 383, 564-573. http://www.ncbi.nlm.nih.gov/pubmed/24351320 https://doi.org/10.1016/S0140-6736(13)62225-4
[10]
Randall, T.C. and Ghebre, R. (2016) Challenges in Prevention and Care Delivery for Women with Cervical Cancer in Sub-Saharan Africa. Frontiers in Oncology, 6, 160. http://www.ncbi.nlm.nih.gov/pubmed/27446806 https://doi.org/10.3389/fonc.2016.00160
[11]
Vaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S. and Bray, F. (2013) Worldwide Trends in Cervical Cancer Incidence: Impact of Screening against Changes in Disease Risk Factors. European Journal of Cancer, 49, 3262-3273. https://doi.org/10.1016/j.ejca.2013.04.024
[12]
WHO (2020) A Global Strategy for Elimination of Cervical Cancer. Who.int.
[13]
WHO (2018). http://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/
[14]
Canfell, K., Kim, J.J., Brisson, M., Keane, A., Simms, K.T., Caruana, M., et al. (2020) Mortality Impact of Achieving WHO Cervical Cancer Elimination Targets: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries. The Lancet, 395, 591-603. https://doi.org/10.1016/S0140-6736(20)30157-4
[15]
(2019) Healthy Environments for Healthier Populations: Why Do They Matter, and What Can We Do? World Health Organization, Geneva.
[16]
Rudan, I., Chopra, M., Kapiriri, L., Gibson, J., Lansang, M.A., et al. (2008) Setting Priorities in Global Child Health Research Investments: Universal Challenges and Conceptual Framework. Croatian Medical Journal, 49, 307-317. https://doi.org/10.3325/cmj.2008.3.307
[17]
Ali, M., Farron, M., Quedraogo, L., Mahaini, R.K., Miller, K. and Kabra, R. (2018) Research Gaps and Emerging Priorities in Sexual and Reproductive Health in Africa and Eastern Mediterranean Regions. Reproductive Health Journal, 15, Article No. 39. https://doi.org/10.1186/s12978-018-0484-9
[18]
Mendis, S. and Alwan, A., Eds. (2011) Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases. World Health Organization, Geneva.
[19]
Souza, J.P., Widmer, M., Gülmezoglu, A.M., Lawrie, T.A., Adejuyigbe, E.A., Carroli, G., Crowther, C., Currie, S.M., Dowswell, T., Hofmeyr, J., et al. (2014) Maternal and Perinatal Health Research Priorities beyond 2015: An International Survey and Prioritization Exercise. Reproductive Health, 11, Article No. 61. https://doi.org/10.1186/1742-4755-11-61
[20]
Datta, S., Pink, J., Medley, G.F., et al. (2019) Assessing the Cost-Effectiveness of HPV Vaccination Strategies for Adolescent Girls and Boys in the UK. BMC Infectious Diseases, 19, Article No.: 552. https://doi.org/10.1186/s12879-019-4108-y
[21]
Santos, A.C.d., Silva, N.N.T., Carneiro, C.M., et al. (2020) Knowledge about Cervical Cancer and HPV Immunization Dropout Rate among Brazilian Adolescent Girls and Their Guardians. BMC Public Health, 20, Article No. 301. https://doi.org/10.1186/s12889-020-8410-9
[22]
Marty, R., Roze, S., Bresse, X., Largeron, N. and Smith-Palmer, J. (2013) Estimating the Clinical Benefits of Vaccinating Boys and Girls against HPV-Related Diseases in Europe. BMC Cancer, 13, Article No.: 10. https://doi.org/10.1186/1471-2407-13-10
[23]
Brisson, M., Kim, J.J., Canfell, K., Drolet, M., Gingras, G., Burger, E.A., Martin, D., et al. (2020) Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries. The Lancet, 395, 575-590. https://doi.org/10.1016/S0140-6736(20)30068-4
[24]
Nahvijou, A., Hadji, M., Barati Marnani, A., et al. (2014) A Systematic Review of Economic Aspects of Cervical Cancer Screening Strategies Worldwide: Discrepancy between Economic Analysis and Policymaking. Asian Pacific Journal of Cancer Prevention, 15, 8229-8237. https://doi.org/10.7314/APJCP.2014.15.19.8229
[25]
Cutts, F.T., Franceschi, S., Goldie, S., et al. (2007) Human Papillomavirus and HPV Vaccines: A Review. Bulletin of the World Health Organization, 85, 719-726. https://doi.org/10.2471/BLT.06.038414
[26]
Compaore, S., Ouedraogo, C.M.R., Koanda, S., Haynatzki, G., Chamberlain, R.M. and Soliman, A.S. (2016) Barriers to Cervical Cancer Screening in Burkina Faso: Needs for Patient and Professional Education. Journal of Cancer Education, 31, 760-766. https://doi.org/10.1007/s13187-015-0898-9
[27]
World Health Organization (2013) Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. World Health Organization, Geneva.
